Posted by Christopher Mengel on Jan 27th, 2025
Shares of Mersana Therapeutics, Inc. (NASDAQ:MRSN – Get Free Report) have been given an average rating of “Moderate Buy” by the eight ratings firms that are presently covering the company, Marketbeat reports. Two...
More of this article »